首页 | 本学科首页   官方微博 | 高级检索  
     


Consensus and disputes on the adjuvant therapy for non-small cell lung cancer with positive surgical margins
Authors:Yuan Meng  Men Yu  Kang Jingjing  Sun Xin  Zhao Maoyuan  Yang Xu  Bao Yongxing  Hui Zhouguang
Affiliation:1.Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;2.Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Abstract:For non-small cell lung cancer (NSCLC) patients with positive surgical margins, the survival rates can be dramatically decreased. However, high-level evidence is lacking in the standard adjuvant treatment for NSCLC patients with positive surgical margins. In this article, consensus and disputes on the adjuvant therapy for NSCLC patients with positive surgical margins were reviewed.
Keywords:Carcinoma   non-small cell lung/positive surgical margin  Carcinoma   non-small cell lung/postoperative adjuvant therapy  Consensus and dispute  
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号